| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sionna Therapeutics, Inc. (SION) has 10 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. SION is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.90M | $257.28M | - | |
| 10% | 6.74M | $251.59M | - | |
| Dir | 2.67M | $99.66M | -101 | |
| Dir | 2.67M | $99.66M | -101 | |
| Dir | 2.31M | $86.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | Ridloff Elena48 | CFO &Head Of Corp. Dev. | Sell | 52,000 | $21.62 | $1,124,335.00 | -24.5% | +71.8% | - | |
| Jun 27, 2025 | Tpg GP A, LLC77 | 10% Owner | Buy | 60,000 | $15.84 | $950,400.00 | +0.9% | +73.6% | - | |
| Feb 10, 2025 | Booth Bruce70 | Director | Buy | 60,000 | $18.00 | $1,080,000.00 | +8.0% | -42.0% | +70.9% | |
| Feb 10, 2025 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,125,000 | $18.00 | $20,250,000.00 | +13.8% | -42.0% | +70.9% | |
| Feb 10, 2025 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Buy | 60,000 | $18.00 | $1,080,000.00 | +8.0% | -42.0% | +70.9% | |
| Feb 10, 2025 | Orbimed Advisors LLC67 | Director | Buy | 550,000 | $18.00 | $9,900,000.00 | +17.4% | -42.0% | +70.9% | |
| Feb 10, 2025 | Thompson Peter A.65 | Director | Buy | 550,000 | $18.00 | $9,900,000.00 | +17.4% | -42.0% | +70.9% | |
| Feb 10, 2025 | Tpg GP A, LLC77 | - | Buy | 1,125,000 | $18.00 | $20,250,000.00 | +20.2% | -42.0% | +70.9% |